Barclays Hopes Pulmicort Is 'Back For Good' At Actavis
May 08, 2015 at 10:22 AM EDT
In a report published Friday, Barclays analysts maintained an Equal-Weight rating on Actavis Plc. (NYSE: ACT), with a price target of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.